| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/24/2009 | US7507759 Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione |
| 03/24/2009 | US7507753 Biaryl compound and use thereof |
| 03/24/2009 | US7507746 Enantiomer of tenatoprazole and the use thereof in therapy |
| 03/24/2009 | US7507744 Spiroazabicyclic heterocyclic compounds |
| 03/24/2009 | US7507730 Substituted pyrazolo[1,5-a]pyrimidines as potassium channel activators |
| 03/24/2009 | US7507723 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 03/24/2009 | US7507572 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 03/24/2009 | US7507564 Tiacumicin production |
| 03/24/2009 | US7507542 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507403 drugs comprising an isolated protein, mixed with pharmaceutically acceptable carriers, excipients or diluents, used as an immunogenic composition for stimulating or enhancing the production of antibodies directed against the protein |
| 03/24/2009 | CA2431100C Dihydroindole and tetrahydroquinoline derivatives |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/19/2009 | WO2009035497A2 Disease related cysteine modifications and uses thereof |
| 03/19/2009 | WO2009035387A1 A medicament prepared using methotrexate and suitable for topical administration, for the treatment of a lower gastrointestinal tract inflammatory disease |
| 03/19/2009 | WO2009035068A1 Novel 1,3,3-trimethyl-7-phenyl-3,4-dihydro-1h-quinoxalin- 2-one derivatives |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009035055A1 Insulin-like growth factor-1 (igf-1) production promoter |
| 03/19/2009 | WO2009034325A1 Isoflavone formulation |
| 03/19/2009 | WO2009033795A2 Use of a obestatin as a therapeutic agent |
| 03/19/2009 | WO2009033794A2 Use of endothelin-1, optionally in combination with obestatin, as a therapeutic agent |
| 03/19/2009 | WO2009033789A2 Use of a peptide as a therapeutic agent |
| 03/19/2009 | WO2009033788A2 Use of a jck-301, optionally in combination with big endothelin, as a therapeutic agent. |
| 03/19/2009 | WO2009033777A1 Leuprolide analog as a therapeutic agent |
| 03/19/2009 | WO2009033774A2 Use of a laminin nonapeptide as a therapeutic agent |
| 03/19/2009 | WO2009033773A2 Use endothelin 2, alone or combined with a nonapeptide, a peptide as a therapeutic agent |
| 03/19/2009 | WO2009033762A2 Use of endothelin-3 as a therapeutic agent |
| 03/19/2009 | WO2009033761A2 Use of a fragment of hcv nucleo protein, alone or together with endothelin-3, as a therapeutic agent |
| 03/19/2009 | WO2009033726A2 Use of cart (55-102), optionally in combination with tuftsin, as a therapeutic agent |
| 03/19/2009 | WO2009033678A2 Use of a tuftsin as a therapeutic agent |
| 03/19/2009 | WO2009033515A1 Sesquiterpenes and derivatives thereof for use as feed additives |
| 03/19/2009 | WO2009033360A1 Benzamide derivatives, their preparation and uses in medicine thereof |
| 03/19/2009 | WO2009033268A1 Novel polysaccharide immunogens from clostridium difficile |
| 03/19/2009 | WO2009000296A3 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 03/19/2009 | WO2008143916A3 Prokinetic agent for bowel preparation |
| 03/19/2009 | US20090076256 Degradation-resistant mononucleoside phosphate compounds |
| 03/19/2009 | US20090076148 Deuterium-enriched pravastatin |
| 03/19/2009 | US20090076106 2-(Phenylamino) Benzimidazole Derivatives and Their Use as Modulators of Small- Conductance Calcuim-Activated Potassium Channels |
| 03/19/2009 | US20090076089 Deuterium-enriched pantoprazole |
| 03/19/2009 | US20090076082 Deuterium-enriched alvimopan |
| 03/19/2009 | US20090076070 Hetero compound |
| 03/19/2009 | US20090076051 Deuterium-enriched methylnaltrexone |
| 03/19/2009 | US20090076030 Piperazine compounds |
| 03/19/2009 | US20090076008 Deuterium-enriched fosaprepitant |
| 03/19/2009 | US20090076007 Deuterium-enriched aprepitant |
| 03/19/2009 | US20090075981 INHIBITORS OF p38 |
| 03/19/2009 | US20090075978 Substituted propiolic acid amides and their use for producing drugs |
| 03/19/2009 | US20090075952 Nitroderviatives as drugs for diseases having an inflammatory basis |
| 03/19/2009 | US20090075890 Long lasting synthetic exendin-4 peptide conjugates and methods of use thereof |
| 03/19/2009 | US20090075864 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/19/2009 | US20090074890 Substituted Triazoles as Sodium Channel Blockers |
| 03/19/2009 | US20090074863 Dosage Forms Containing A PPI, NSAID And A Buffer |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074830 Anti-angiogenic compositions and methods of use |
| 03/19/2009 | US20090074788 Antibody Against Periostin, and a Pharmaceutical Composition comprising it for Preventing or Treating a Disease in which Periostin is Involved |
| 03/19/2009 | US20090074754 Methods and compositions useful in the treatment of mucositis |
| 03/19/2009 | US20090074680 Statherin peptide and use in medicine |
| 03/19/2009 | DE112005003001B4 Aus humanem Fettgewebe abgeleitete multipotente Stammzellen und diese enthaltende Zelltherapeutika Derived from human adipose tissue stem cells and multipotent stem cell therapeutics containing them |
| 03/19/2009 | CA2698980A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698821A1 Use of a peptide as a therapeutic agent |
| 03/19/2009 | CA2698157A1 Novel polysaccharide immunogens from clostridium difficile |
| 03/18/2009 | EP2036905A1 Pyridylisoxazole derivative |
| 03/18/2009 | EP2036895A1 Hsp90 inhibitor |
| 03/18/2009 | EP2036891A2 Isoquinoline inhibitors of P38 |
| 03/18/2009 | EP2036564A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 03/18/2009 | EP2036560A1 (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy |
| 03/18/2009 | EP2036557A1 Antitumor agent for thyroid cancer |
| 03/18/2009 | EP2036540A2 Improved injectable dispersions of propofol |
| 03/18/2009 | EP2035409A1 Benzimidazole derivatives which are to be used as anatgonist for the cb1-receptor |
| 03/18/2009 | EP2035021A2 Treatment of mouth and urinary tract infections |
| 03/18/2009 | EP2035010A1 Modulation of the immune system by inositol phospholipids |
| 03/18/2009 | EP2035008A2 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals |
| 03/18/2009 | EP2034952A2 Aprepitant compositions |
| 03/18/2009 | EP2034855A2 Food compositions and methods of treating periodontal disease |
| 03/18/2009 | EP2034854A1 Nutritional formulation |
| 03/18/2009 | EP2034844A2 Method for treatment of diarrhea-predominant irritable bowel syndrome |
| 03/18/2009 | EP2034816A1 O-glycans in the treatment of inflammatory bowel disease and cancers |
| 03/18/2009 | EP1765807B1 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation |
| 03/18/2009 | EP1539927B1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1353624B1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 03/18/2009 | EP1218498B1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 03/18/2009 | CN101389656A Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same |
| 03/18/2009 | CN101389610A Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 03/18/2009 | CN101389339A Therapeutic agent for diabetes |
| 03/18/2009 | CN101389317A Controlled release solid preparation |
| 03/18/2009 | CN101389316A Controlled release solid preparation |
| 03/18/2009 | CN101385856A Controllable slow-releasing nano hydroxyapatite with efficient absorption for antalzyme and preparation method thereof |
| 03/18/2009 | CN101385850A Treatment of cellular proliferative disorders |
| 03/18/2009 | CN101385846A Preparation method of Jiawei Xiaoyao power preparation |
| 03/18/2009 | CN101385845A Traditional Chinese medicine preparation for treating hepatitis B |
| 03/18/2009 | CN101385842A Medicine for treating chronic hepatitis b and preparation method thereof |
| 03/18/2009 | CN101385840A Anluo Huaxian medicine and preparation method thereof |
| 03/18/2009 | CN101385837A Chinese prepared medicine for treating gastrosis |
| 03/18/2009 | CN101385827A Sea cucumber health paste and production method thereof |
| 03/18/2009 | CN101385823A Medicine for treating heavy acute pancreatitis and preparation method thereof |
| 03/18/2009 | CN101385816A Traditional Chinese medicine powder for treating liver disease |
| 03/18/2009 | CN101385808A Quality control method of Zhubai tranquilizing pill |
| 03/18/2009 | CN101385804A New use of traditional Chinese medicine formulation |
| 03/18/2009 | CN101385803A Compound Chinese herbal medicine extract liquid for preventing and treating livestock and birds diarrhea and preparation thereof |